Compare ARK Genomic Revolution ETF (ARKG) vs iShares Self-Driving EV and Tech (IDRV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares Self-Driving EV and Tech — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while iShares Self-Driving EV and Tech trades at $36.65. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares Self-Driving EV and Tech nearer its low. Which is the better fit depends on your goals.
| ARKG | IDRV | |
|---|---|---|
Sector | Sector/Thematic | Sector/Thematic |
52-Week High | $43.57 | $45.48 |
52-Week Low | $23.09 | $32.13 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
IDRV trades at $36.86 with a slight 0.33% daily gain, but technical indicators signal a bearish trend with 19 sell signals versus 3 buys. The stock faces resistance at $37-$38 while finding support at $35-$36. Recent news highlights strong global EV sales growth, particularly in China and Europe, though U.S. adoption remains slower. Key financial ratios including P/E, P/S, and ROE are currently unavailable for analysis.
The EV sector shows promising growth catalysts from rising fuel prices and expanding global adoption, but IDRV faces technical headwinds and competitive pressures. Investment appeal depends on improved fundamental metrics and sector momentum overcoming current bearish technical positioning. Regulatory developments and Chinese market expansion present both opportunities and risks for shareholders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares Self-Driving EV and Tech
IDRV invests in global companies at the forefront of self-driving and electric vehicle innovation. It provides exposure to the full EV value chain, including battery technology and autonomous systems, with top holdings like Albemarle, Rivian, and Tesla.
Read more on IDRV →
